Equitalist

Equitalist logo

Jupiter Life Line Hospitals Limited

BSE: 543980 | NSE: JLHL

Sector: Healthcare | Industry: Hospital

Jupiter Hospital Logo
REVENUE
₹ 1,500 Crore
Topline YoY ▲ 18.9%
GROSS PROFIT
₹ 1,213 Crore
Cost efficiency ▲ 17.6%
EBITDA
₹ 343 Crore
Operating leverage ▲ 15.8%
NET PROFIT
₹ 194 Crore
Net profitability ▲ 0.4%

01

ABOUT COMPANY

Jupiter Life Line Hospitals Limited ( hereinafter as “JLHL“ or “The Company” or “Company”) was incorporated on 18th November 2002. The company started its operations in 2007 and has significant presence in Western India. In FY24, the company went public. The primary promoters of the company are Dr. Ajay Thakker and Dr. Ankit Thakker.

JLHL is one of the prominent multi-speciality tertiary and quaternary healthcare provider hospitals in Western India. Unlike the “Spoke and Hub” model, JLHL’s hospitals are designed as an independent and fully equipped hospitals. Each facility is capable of delivering comprehensive, high-quality tertiary and quaternary care independently, managing even the most complex medical cases. JLHL offers more than 30 specialised treatments across the hospitals such as Cardiology, Oncology, Orthopaedics, Dermatology, Gastroenterology etc. JLHL is also operating hotel, Fortune Park Lake City Hotel, in Thane, which is strategically used to promote medical tourism.

State Hospital Location Status Est. / Expected Operational Beds Planned Total Capacity Key Highlights / Investment
Madhya Pradesh Indore (Vishesh Jupiter) Operational 2020 309 431 Acquired facility; brownfield expansion underway.
Maharashtra Dombivli, MMR Operational Feb-26 200 500 ?425 Cr investment; built in 25 months.
Pune (Bibvewadi / South) Upcoming 2028 — 500 Phased addition (Phase I: 200–220 beds).
Mira–Bhayandar Upcoming 2029 — 300 Estimated project investment of ?400 Cr.
Bandra-Kurla Complex (BKC) Upcoming 2030 — 400 Quaternary facility on leased land parcel.
Thane, Maharashtra Operational 2007 364 364 Multi-speciality flagship facility.
Baner, Pune Operational 2017 375 386 11 additional beds expected.
Metric Value
Hospitals 4
Specialities 30+
Doctors 2,052
Operational Beds 1,248
Occupancy 61.20%
Company Highlights Value
Operating Hospitals 3
Key Specialties Offered 30+
Total Bed Capacity 1194
Operational Bed Capacity 1061
New Hospital Beds Added in FY 2024-25 100
Doctors 1275
Occupancy Rate 65.3%
Increase in Revenue 17.5%
Cardiology Gastroenterology Neurology and Neurosciences Rheumatology
Oncology Infectious Diseases Paediatrics Urology
Orthopaedics Nephrology Organ Transplant Endocrinology and Diabetes
Dermatology Nutrition and Dietetics Haematology Ophthalmology
THANE, MAHARASHTRA
Metric Value
Year 2007
Total Bed Capacity 364
Operational Beds 364
BANER, PUNE
Metric Value
Year 2017
Total Bed Capacity 386
Operational Beds 375
Expected Bed Addition 11
DOMBIVLI, MUMBAI
Metric Value
Year 2026
Total Bed Capacity 500
Operational Beds 200
Expected Bed Addition 300
MIRA–BHAYANDAR
Metric Value
Year 2029 (Expected)
Total Bed Capacity 300
Expected Bed Addition Phase I 150-170
Expected Bed Addition Phase II 130-150
PUNE (SOUTH)
Metric Value
Year 2028 (Expected)
Total Bed Capacity 500
Expected Bed Addition Phase I 200-220
Expected Bed Addition Phase II 280-300
BANDRA-KURLA COMPLEX
Metric Value
Year 2030 (Expected)
Total Bed Capacity 400
INDORE, MADHYA PRADESH
Metric Value
Year 2020
Total Bed Capacity 431
Operational Beds 309
Expected Bed Addition Phase I 11
Expected Bed Addition Phase II 111
Location Number of Hospitals Number of Offices Total
National 4* 1 5
International 0 0 0
* This includes one hospital currently under construction in Dombivli and a dialysis centre.
Location Type Total Count
National (No. of states) 1
International (No. of countries) 0
Multi-Slice PET/CT Catheterisation Labs Anti-Gravity Treadmills & Gait Analysing Treadmills 128 Slice CT Scanners Endoscopic Ultrasound and Endo-Bronchial Ultrasound
Stereotactic LINAC Brachytherapy Robotic Knee Replacement Sleep Labs Cognition Training and Rehabilitation
3 Tesla MRI Non-Invasive Cardiac Labs Robotic Gait Trainers Robotic Neuro Rehabilitation

02

Earning Calls Summary

Management Earnings Calls

Quarterly concall summaries, management commentary tracker & key metrics

Q1     FY 2027

Dombivli Completes First Full Quarter; EBITDA Drag of ₹9.5 Cr

Management opened noting Dombivli Hospital has completed its first full quarter of operations with warm reception from both patients and the medical community. The other 3 operating hospitals and 3 upcoming projects are all on track and progressing as per earlier discussions.

Q1 FY27 EBITDA MARGIN 19.3% (impacted by Dombivli drag)
Q1 FY27 ARPOB ₹73,500 (up from ₹67,700 in FY26)
DOMBIVLI EBITDA LOSS ₹9.5 crores for Q1 FY27
Key Takeaway: Dombivli Hospital completed its first full quarter of operations with a ₹9.5 crores EBITDA drag, in line with expectations, while total income grew to ₹411 crores with ARPOB of ₹73,500 and the company maintaining a near-zero net debt position.

Concall Notes

PREMIUM
PREMIUM
Unlock Comprehensive Analysis
Get deeper insights with detailed financials, forecasts, ratios & valuation
Revenue & Gross Margin
EBITDA & Dividend
10Y Forecasted P&L
Balance Sheet
DuPont & Ratio Analysis
Valuation & more
Premium insights for smarter investing

Upgrade to access institutional-quality research & analysis.

Upgrade to Access
30-Day Free Trial
Disclaimer

The research report presented here is for informational and research purposes only. It reflects our own views, assumptions, and analysis and is not intended as a recommendation, offer, or solicitation to buy, sell, or hold any security or asset. Please conduct your own due diligence and consult a qualified financial advisor before making any investment decision. Please check our Terms & Conditions page before investing.

Scroll to Top